Stored red blood cells: A changing universe waiting for its map(s)

Journal of Proteomics

Volumn 73, Issue 3, 2010, Pages 374-385

  Lion, Niels ^a,b   Crettaz, David ^a   Rubin, Olivier ^a   Tissot, Jean Daniel ^a  

^a Service Regional Vaudois de Transfusion Sanguine   (Switzerland)

^b EPFL   (Switzerland)

Author keywords

Band 3 clustering; Blood banking; Blood storage lesion; Eryptosis; Erythrocyte; RBC; RBC microvesicle; Red blood cell; Senescence

Indexed keywords

ERYTHROCYTE BAND 3 PROTEIN;

ANEMIA; BLEEDING; BLOOD DONOR; CELL AGING; CELL STRESS; ERYTHROCYTE PRESERVATION; ERYTHROCYTE TRANSFUSION; HUMAN; HYPEROSMOTIC STRESS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEOMICS; REVIEW;

EID: 72149105913     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2009.11.001     Document Type: Review

References (149)

1. Bennett-Guerrero E., Veldman T.H., Doctor A., Telen M.J., Ortel T.L., Reid T.S., et al. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci USA 104 (2007) 17063-17068
2. Hess J.R., and Greenwalt T.G. Storage of red blood cells: new approaches. Transfus Med Rev 16 (2002) 283-295
3. Meryman H.T., Hornblower M.L.S., and Syring R.L. Prolonged storage of red-cells at 4-degrees-C. Transfusion 26 (1986) 500-505
4. Koch C.G., Li L., Sessler D.I., Figueroa P., Hoeltge G.A., Mihaljevic T., et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 358 (2008) 1229-1239
5. Hess JR. Blood storage, personnal communication, Viterbo, Italy.
6. Anniss A.M., and Sparrow R.L. Variable adhesion of different red blood cell products to activated vascular endothelium under flow conditions. Am J Hematol 82 (2007) 439-445
7. Bosman G.J.C.G.M., Werre J.M., and Willekens F.L.A. Novotn√Ω VMJ. Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion. Transfus Med 18 (2008) 335-347
8. van de Watering L.M.G., and Brand A. Effects of storage of red cells. Transfusion Medicine and Hemotherapy 35 (2008) 359-367
9. Holme S. Current issues related to the quality of stored RBCs. Transf Apheres Sci 33 (2005) 55-61
10. Jia L., Bonaventura C., Bonaventura J., and Stamler J.S. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 380 (1996) 221-226
11. De Rosa M.C., Alinovi C.C., Galtieri A., Scatena R., and Giardina B. The plasma membrane of erythrocytes plays a fundamental role in the transport of oxygen, carbon dioxide and nitric oxide and in the maintenance of the reduced state of the heme iron. Gene 398 (2007) 162-171
12. Isbell T.S., Sun C.W., Wu L.C., Teng X.J., Vitturi D.A., Branch B.G., et al. SNO-hemoglobin is not essential for red blood cell-dependent hypoxic vasodilation. Nat Med 14 (2008) 773-777
13. Reynolds J.D., Ahearn G.S., Angelo M., Zhang J., Cobb F., and Stamler J.S. S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood. Proc Natl Acad Sci USA 104 (2007) 17058-17062
14. Klein H.G., Spahn D.R., and Carson J.L. Transfusion Medicine 1 - red blood cell transfusion in clinical practice. Lancet 370 (2007) 415-426
15. Hogman C.F., and Meryman H.T. Storage parameters affecting red blood cell survival and function after transfusion. Transfus Med Rev 13 (1999) 275-296
16. Cho J., King J.S., Qian X., Harwood A.J., and Shears S.B. Dephosphorylation of 2, 3-bisphosphoglycerate by MIPP expands the regulatory capacity of the Rapoport-Luebering glycolytic shunt. Proc Natl Acad Sci USA 105 (2008) 5998-6003
17. Beutler E., and Wood L. In vivo regeneration of red cell 2,3 diphosphoglyceric acid (DPG) after transfusion of stored blood. J Lab Clin Med 74 (1969) 300
18. Valeri C.R., and Collins F.B. Physiologic effect of transfusing preserved red cells with low 2,3-diphosphoglycerate and high affinity for oxygen. Vox Sang 20 (1971) 397
19. Willekens F.L.A., Werre J.M., Groenen-Dopp Y.A.M., Roerdinkholder-Stoelwinder B., De Pauw B., and Bosman G.J.C.G.M. Erythrocyte vesiculation: a self-protective mechanism?. Br J Haematol 141 (2008) 549-556
20. Rubin O., Crettaz D., Canellini G., Tissot J.D., and Lion N. Microparticles in stored red blood cells: an approach using flow cytometry and proteomic tools. Vox Sang 95 (2008) 289-297
21. Greenwalt T.J. The how and why of exocytic vesicles. Transfusion 46 (2006) 143-152
22. Kriebardis A.G., Antonelou M.H., Stamoulis K.E., Economou-Petersen E., Margaritis L.H., and Papassideri I.S. Storage-dependent remodeling of the red blood cell membrane is associated with increased immunoglobulin G binding, lipid raft rearrangement, and caspase activation. Transfusion 47 (2007) 1212-1220
23. Wolfe L.C., Byrne A.M., and Lux S.E. Molecular defect in the membrane skeleton of blood-bank stored red-cells - abnormal spectrin protein 4.1-actin complex-formation. J Clin Invest 78 (1986) 1681-1686
24. Kriebardis A.G., Antonelou M.H., Stamoulis K.E., Economou-Petersen E., Margaritis L.H., and Papassideri I.S. Membrane protein carbonylation in non-leukodepleted CPDA-preserved red blood cells. Blood Cells Mol Dis 36 (2006) 279-282
25. Kriebardis A.G., Antonelou M.H., Stamoulis K.E., Economou-Petersen E., Margaritis L.H., and Papassideri I.S. Progressive oxidation of cytoskeletal proteins and accumulation of denatured hemoglobin in stored red cells. J Cell Mol Med 11 (2007) 148-155
26. Stewart A., Urbaniak S., Turner M., and Bessos H. The application of a new quantitative assay for the monitoring of integrin-associated protein CD47 on red blood cells during storage and comparison with the expression of CD47 and phosphatidylserine with flow cytometry. Transfusion 45 (2005) 1496-1503
27. Mitrofan-Oprea L, Palii C, Tissier JP, Héron A, Verpoort T, Behague M, Smagghe E, Schooneman F, Huart JJ, Goudaliez F, Montreuil J, Bratosin D. Novel criteria for assessing red blood cell viability in blood banks. Nouveaux critères d'évaluation de la viabilité des hématies destinées à la transfusion 2007; 14: 393-401.
28. Bosman G.J.C.G.M., Willekens F.L.A., and Werre J.M. Erythrocyte aging: a more than superficial resemblance to apoptosis?. Cell Physiol Biochem 16 (2005) 1-8
29. Sparrow R.L., Veale M.F., Healey G., and Payne K.A. Red blood cell (RBC) age at collection and storage influences RBC membrane-associated carbohydrates and lectin binding. Transfusion 47 (2007) 966-968
30. Bratosin D., Mazurier J., Debray H., Lecocq M., Boilly B., Alonso C., et al. Flow cytofluorimetric analysis of young and senescent human erythrocytes probed with lectins. Evidence that sialic acids control their life span. Glycoconj J 12 (1995) 258-267
31. Lang F., Lang K.S., Wieder T., Myssina S., Birka C., Lang P.A., et al. Cation channels, cell volume and the death of an erythrocyte. Pflugers Arch 447 (2003) 121-125
32. Lang F., Birka C., Myssina S., Lang K.S., Lang P.A., Tanneur V., et al. Erythrocyte ion channels in regulation of apoptosis. Adv Exp Med Biol 559 (2005) 211-217
33. Lang K.S., Lang P.A., Bauer C., Duranton C., Wieder T., Huber S.M., et al. Mechanisms of suicidal erythrocyte death. Cell Physiol Biochem 15 (2005) 195-202
34. Wieder T., Lang P.A., Lang K.S., Kempe D.S., Niemoeller O.M., Duranton C., et al. Studying mechanisms of eryptosis. Cytotechnology 49 (2005) 117-132
35. Lang F., Lang K.S., Lang P.A., Huber S.M., and Wieder T. Mechanisms and significance of eryptosis. Antioxid Redox Signal 8 (2006) 1183-1192
36. Lang F., Huber S.M., Szabo I., and Gulbins E. Plasma membrane ion channels in suicidal cell death. Arch Biochem Biophys 462 (2007) 189-194
37. Föller M., Huber S.M., and Lang F. Erythrocyte programmed cell death. IUBMB life 60 (2008) 661-668
38. Lang F., Gulbins E., Lerche H., Huber S.M., Kempe D.S., and Foller M. Eryptosis, a window to systemic disease. Cell Physiol Biochem 22 (2008) 373-380
39. Lang P.A., Kempe D.S., Myssina S., Tanneur V., Birka C., Laufer S., et al. PGE2 in the regulation of programmed erythrocyte death. Cell Death Differ 12 (2005) 415-428
40. Lang K.S., Myssina S., Brand V., Sandu C., Lang P.A., Berchtold S., et al. Involvement of ceramide in hyperosmotic shock-induced death of erythrocytes. Cell Death Differ 11 (2004) 231-243
41. Nicolay J., Bentzen P.J., Ghashghaeinia M., Wieder T., and Lang F. Stimulation of erythrocyte cell membrane scrambling by amiodarone. Cell Physiol Biochem 20 (2007) 1043-1050
42. Sopjani M., Foeller M., and Lang F. Gold stimulates Ca2+ entry into and subsequent suicidal death of erythrocytes. Toxicology 244 (2008) 271-279
43. Foeller M., Huber S.M., and Lang F. Erythrocyte programmed cell death. Iubmb Life 60 (2008) 661-668
44. Lang F., Gulbins E., Lerche H., Huber S.M., Kempe D.S., and Foeller M. Eryptosis, a window to systemic disease. Cellular Physiology and Biochemistry 22 (2008) 373-380
45. Zaidi A., and Saleemuddin M. Ca2+-induced alterations in the activity of membrane (Ca2+-Mg2+)-atpase of human and rat erythrocytes. Indian Journal of Biochemistry & Biophysics 30 (1993) 98-102
46. Redding G.S., Record D.M., and Raess B.U. Calcium-stressed erythrocyte-membrane structure and function for assessing glipizide effects on transglutaminase activation. Proc Soc Exp Biol Med 196 (1991) 76-82
47. Low P.S., Allen D.P., and Zioncheck T.F. Tyrosine phosphorylation of band 3 inhibits peripheral protein binding. J Biol Chem 262 (1987) 4592-4596
48. Yannoukakos D., Meyer H.E., Vasseur C., Driancourt C., Wajcman H., and Bursaux E. Three regions of erythrocyte band 3 protein are phosphorylated on tyrosines: characterization of the phosphorylation sites by solid phase sequencing combined with capillary electrophoresis. Biochimica et Biophysica Acta - Biomembranes 1066 (1991) 70-76
49. Yannoukakos D., Vasseur C., Piau J.P., Wajcman H., and Bursaux E. Phosphorylation sites in human erythrocyte band 3 protein. Biochimica et Biophysica Acta - Biomembranes 1061 (1991) 253-266
50. Willardson B.M., Thevenin B.J.M., Harrison M.L., Kuster W.M., Benson M.D., and Low P.S. Localization of the ankyrin-binding site on erythrocyte membrane protein, band 3. J Biol Chem 264 (1989) 15893-15899
51. Thevenin B.J.M., and Low P.S. Kinetics and regulation of the ankyrin-band 3 interaction of the human red blood cell membrane. J Biol Chem 265 (1990) 16166-16172
52. Harrison M.L., Rathinavelu P., Arese P., Geahlen R.L., and Low P.S. Role of band 3 tyrosine phosphorylation in the regulation of erythrocyte glycolysis. J Biol Chem 266 (1991) 4106-4111
53. Low P.S., Willardson B.M., Mohandas N., Rossi M., and Shohet S. Contribution of the band 3-ankyrin interaction to erythrocyte membrane mechanical stability. Blood 77 (1991) 1581-1586
54. Low P.S., Rathinavelu P., and Harrison M.L. Regulation of glycolysis via reversible enzyme binding to the membrane protein, band 3. J Biol Chem 268 (1993) 14627-14631
55. Weber R.E., Voelter W., Fago A., Echner H., Campanella E., and Low P.S. Modulation of red cell glycolysis: interactions between vertebrate hemoglobins and cytoplasmic domains of band 3 red cell membrane proteins. Am J Physiol Regul Integr Comp Physiol 287 (2004) R454-R464
56. Sopjani M., Foller M., Dreischer P., and Lang F. Stimulation of eryptosis by cadmium ions. Cellular Physiology and Biochemistry 22 (2008) 245-252
57. Sopjani M., Foller M., Gulbins E., and Lang F. Suicidal death of erythrocytes due to selenium-compounds. Cellular Physiology and Biochemistry 22 (2008) 387-394
58. Tan T.N., Foller M., and Lang F. Tin triggers suicidal death of erythrocytes. J Appl Toxicol 29 (2009) 79-83
59. Kucherenko Y., Geiger C., Shumilina E., FoÃàller M., and Lang F. Inhibition of cation channels and suicidal death of human erythrocytes by zidovudine. Toxicology 253 (2008) 62-69
60. Mahmud H., Foller M., and Lang F. Suicidal erythrocyte death triggered by cisplatin. Toxicology 249 (2008) 40-44
61. Lang F., Lang K.S., Lang P.A., Huber S.M., and Wieder T. Osmotic shock-induced suicidal death of erythrocytes. Acta Physiologica 187 (2006) 191-198
62. Klarl B.A., Lang P.A., Kempe D.S., Niemoeller O.M., Akel A., Sobiesiak M., et al. Protein kinase C mediates erythrocyte "programmed cell death" following glucose depletion. American Journal of Physiology - Cell Physiology 290 (2006) C244-C253
63. Kay M.M.B., Goodman S.R., and Sorensen K. Senescent cell antigen is immunologically related to band 3. Proc Natl Acad Sci USA 80 (1983) 1631-1635
64. Kay M.M.B. Localization of senescent cell antigen on band 3. Proc Natl Acad Sci USA 81 (1984) 5753-5757
65. Kay M.M.B., Flowers N., Goodman J., and Bosman G. Alteration in membrane protein band 3 associated with accelerated erythrocyte aging. Proc Natl Acad Sci USA 86 (1989) 5834-5838
66. Kay M.M.B., Wyant T., and Goodman J. Autoantibodies to band 3 during aging and disease in aging interventions. Ann N Y Acad Sci 719 (1994) 419-447
67. Low P.S., Westfall M.A., Allen D.P., and Appell K.C. Characterization of the reversible conformational equilibrium of the cytoplasmic domain of erythrocyte membrane band 3. J Biol Chem 259 (1984) 13070-13076
68. Christian J.A., Rebar A.H., Boon G.D., and Low P.S. Senescence of canine biotinylated erythrocytes: increased autologous immunoglobulin binding occurs on erythrocytes aged in vivo for 104 to 110 days. Blood 82 (1993) 3469-3473
69. Lutz H.U., and Stringaro-Wipf G. Senescent red cell-bound IgG is attached to band 3 protein. Biomedica Biochimica Acta 42 (1983) S117-S121
70. Lutz H.U., Flepp R., and Stringaro-Wipf G. Naturally occurring autoantibodies to exoplasmic and cryptic regions of band 3 protein, the major integral membrane protein of human red blood cells. J Immunol 133 (1984) 2610-2618
71. Hornig R., and Lutz H.U. Band 3 protein clustering on human erythrocytes promotes binding of naturally occurring anti-band 3 and anti-spectrin antibodies. Exp Gerontol 35 (2000) 1025-1044
72. Arese P., Turrini F., and Schwarzer E. Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes. Cell Physiol Biochem 16 (2005) 133-146
73. Pantaleo A., Giribaldi G., Mannu F., Arese P., and Turrini F. Naturally occurring anti-band 3 antibodies and red blood cell removal under physiological and pathological conditions. Autoimmunity Reviews 7 (2008) 457-462
74. Minetti M., and Malorni W. Redox control of red blood cell biology: the red blood cell as a target and source of prooxidant species. Antioxid Redox Signal 8 (2006) 1165-1169
75. CÃßimen M.Y.B. Free radical metabolism in human erythrocytes. Clin Chim Acta 390 (2008) 1-11
76. Rachmilewitz E.A. Formation of hemichromes from oxidized hemoglobin subunits. Ann N Y Acad Sci 165 (1969) 171-184
77. Rachmilewitz E.A., and Thorell B. Hemichromes in single inclusion bodies in red cells of beta thalassemia. Blood 39 (1972) 794-800
78. Waugh S.M., and Low P.S. Hemichrome binding to band 3: nucleation of Heinz bodies on the erythrocyte membrane. Biochemistry 24 (1985) 34-39
79. Waugh S.M., Walder J.A., and Low P.S. Partial characterization of the copolymerization reaction of erythrocyte membrane band 3 with hemichromes. Biochemistry 26 (1987) 1777-1783
80. Kannan R., Labotka R., and Low P.S. J Biol Chem 263 (1988) 13766-13773
81. Mannu F., Arese P., Cappellini M.D., Fiorelli G., Cappadoro M., Giribaldi G., et al. Role of hemichrome binding to erythrocyte membrane in the generation of band-3 alterations in β-thalassemia intermedia erythrocytes. Blood 86 (1995) 2014-2020
82. Lutz H.U., Stammler P., and Fasler S. How naturally occurring anti-band 3 antibodies stimulate C3b deposition to senescent and oxidatively stressed red blood cells. Biomed Biochim Acta 49 (1990) S224-S229
83. Lutz H.U., Stammler P., Kock D., and Taylor R.P. Opsonic potential of C3b-anti-band 3 complexes when generated on senescent and oxidatively stressed red cells or in fluid phase. Adv Exp Med Biol 307 (1991) 367-376
84. Lutz H.U., Nater M., and Stammler P. Naturally occurring anti-band 3 antibodies have a unique affinity for C3. Immunology 80 (1993) 191-196
85. Jelezarova E., and Lutz H.U. IgG naturally occurring antibodies stabilize and promote the generation of the alternative complement pathway C3 convertase. Mol Immunol 42 (2005) 1393-1403
86. Berg C.P., Engels I.H., Rothbart A., Lauber K., Renz A., Schlosser S.F., et al. Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis. Cell Death Differ 8 (2001) 1197-1206
87. Mandal D., Moitra P.K., Saha S., and Basu J. Caspase 3 regulates phosphatidylserine externalization and phagocytosis of oxidatively stressed erythrocytes. FEBS Lett 513 (2002) 184-188
88. Mandal D., Baudin-Creuza V., Bhattacharyya A., Pathak S., Delaunay J., Kundu M., et al. Caspase 3-mediated proteolysis of the N-terminal cytoplasmic domain of the human erythroid anion exchanger 1 (Band 3). J Biol Chem 278 (2003) 52551-52558
89. Mandal D., Mazumder A., Das P., Kundu M., and Basu J. Fas-, caspase 8-, and caspase 3-dependent signaling regulates the activity of the aminophospholipid translocase and phosphatidylserine externalization in human erythrocytes. J Biol Chem 280 (2005) 39460-39467
90. Ficarra S., Tellone E., Giardina B., Scatena R., Russo A., Misiti F., et al. Derangement of erythrocytic AE1 in beta-thalassemia by caspase 3: pathogenic mechanisms and implications in red blood cell senescence. J Membr Biol 228 (2009) 43-49
91. Bosman G.J.C.G.M., Lasonder E., Luten M., and Roerdinkholder-Stoelwinder B. Novotn√Ω VMJ, Bos H, De Grip WJ. The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion 48 (2008) 827-835
92. Salzer U., Zhu R., Luten M., Isobe H., Pastushenko V., Perkmann T., et al. Vesicles generated during storage of red cells are rich in the lipid raft marker stomatin. Transfusion 48 (2008) 451-462
93. D'Amici G.M., Rinalducci S., and Zolla L. Proteomic analysis of RBC membrane protein degradation during blood storage. Journal of Proteome Research 6 (2007) 3242-3255
94. Cristea I.M., Gaskell S.J., and Whetton A.D. Proteomics techniques and their application to hematology. Blood 103 (2004) 3624-3634
95. Kaiser T., Kamal H., Rank A., Kolb H.J., Holler E., Ganser A., et al. Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation. Blood 104 (2004) 340-349
96. Rees-Unwin K.S., Morgan G.J., and Davies F.E. Proteomics and the haematologist. Clin Lab Haematol 26 (2004) 77-86
97. Seshi B. Proteomics knocks on hematology's door. Blood 103 (2004) 3607-3607
98. Caron M., and Joubert-Caron R. Proteomics in hematologic malignancies. Expert Review of Proteomics 2 (2005) 567-576
99. Thadikkaran L., Siegenthaler M.A., Crettaz D., Queloz P.A., Schneider P., and Tissot J.D. Recent advances in blood-related proteomics. Proteomics 5 (2005) 3019-3034
100. Unwin R.D., and Whetton A.D. How will haematologists use proteomics?. Blood Rev 21 (2007) 315-326
101. Liumbruno G., D'Amici G.M., Grazzini G., and Zolla L. Transfusion medicine in the era of proteomics. Journal of Proteomics 71 (2008) 34-45
102. Zolla L. Proteomics and transfusion medicine. Blood Transfusion 6 (2008) 67-69
103. Lion N., and Tissot J.D. Application of proteomics to hematology: the revolution is starting. Expert Review of Proteomics 5 (2008) 375-379
104. Zolla L, Liumbruno GM, D'Amici GM, Grazzini G. Adverse effects related to storage lesions: Proteomic profiles of red blood cells during storage. Blood Transfusion 2009; 7.
105. Olivieri E., Herbert B., and Righetti P.G. The effect of protease inhibitors on the two-dimensional electrophoresis pattern of red blood cell membranes. Electrophoresis 22 (2001) 560-565
106. Bruschi M., Seppi C., Arena S., Musante L., Santucci L., Balduini C., et al. Proteomic analysis of erythrocyte membranes by soft immobiline gels combined with differential protein extraction. Journal of Proteome Research 4 (2005) 1304-1309
107. Pasini E.M., Kirkegaard M., Mortensen P., Lutz H.U., Thomas A.W., and Mann M. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 108 (2006) 791-801
108. Roux-Dalvai F., de Peredo A.G., Simo C., Guerrier L., Bouyssiee D., Zanella A., et al. Extensive analysis of the cytoplasmic proteome of human erythrocytes using the peptide ligand library technology and advanced mass spectrometry. Molecular & Cellular Proteomics 7 (2008) 2254-2269
109. Simo C., Bachi A., Cattaneo A., Guerrier L., Fortis F., Boschetti E., et al. Performance of combinatorial peptide libraries in capturing the low-abundance proteome of red blood cells. 1. Behavior of mono- to hexapeptides. Anal Chem 80 (2008) 3547-3556
110. Bachi A., Sim C., Restuccia U., Guerrier L., Fortis F., Boschetti E., et al. Performance of combinatorial peptide libraries in capturing the low-abundance proteome of red blood cells. 2. Behavior of resins containing individual amino acids. Anal Chem 80 (2008) 3557-3565
111. Kakhniashvili D.G., Griko N.B., Bulla L.A., and Goodman S.R. The proteomics of sickle cell disease: profiling of erythrocyte membrane proteins by 2D-DIGE and tandem mass spectrometry. Exp Biol Med 230 (2005) 787-792
112. D'Amici G.M., Rinalducci S., and Zolla L. Proteomic analysis of RBC membrane protein degradation during blood storage. J Proteome Res. 6 (2007) 3242-3255
113. Yoshida T., Lee J., McDonough W., Friedman K., and Bitensky M. Anaerobic refrigerated-storage of red blood cells for 9 weeks: in vivo and in vitro characteristics. Transfusion 37 (1997) S414-S414
114. Dumont L.J., Yoshida T., and AuBuchon J.P. Anaerobic storage of red blood cells in a novel additive solution improves in vivo recovery. Transfusion 49 (2009) 458-464
115. Yoshida T., AuBuchon J.P., Dumont L.J., Gorham J.D., Gifford S.C., Foster K.Y., et al. The effects of additive solution pH and metabolic rejuvenation on anaerobic storage of red cells. Transfusion 48 (2008) 2096-2105
116. Yoshida T., AuBuchon J.P., Tryzelaar L., Foster K.Y., and Bitensky M.W. Extended storage of red blood cells under anaerobic conditions. Vox Sang 92 (2007) 22-31
117. Hess J.R. Storage of red blood cells under anaerobic conditions. Vox Sang 93 (2007) 183-183
118. Yoshida T., and AuBuchon J.P. Storage of red blood cells under anaerobic conditions: reply. Vox Sang 93 (2007) 184-184
119. Bosman G., Lasonder E., Luten M., Roerdinkholder-Stoelwinder B., Novotny V.M.J., Bos H., et al. The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion 48 (2008) 827-835
120. Kriebardis A.G., Antonelou M.H., Stamoulis K.E., Economou-Petersen E., Margaritis L.H., and Papassideri I.S. RBC-derived vesicles during storage: ultrastructure, protein composition, oxidation, and signaling components. Transfusion 48 (2008) 1943-1953
121. Galtieri A., Tellone E., Romano L., Misiti F., Bellocco E., Ficarra S., et al. Band-3 protein function in human erythrocytes: effect of oxygenation-deoxygenation. Bba-Biomembranes 1564 (2002) 214-218
122. Teti D., Crupi M., Busa M., Valenti A., Loddo S., Mondello M., et al. Chemical and pathological oxidative influences on band 3 protein anion-exchanger. Cell Physiol Biochem 16 (2005) 77-86
123. Lopez-Otin C., and Overall C.M. Protease degradomics: a new challenge for proteomics. Nat Rev, Mol Cell Biol 3 (2002) 509-519
124. Thiede B., Treumann A., Kretschmer A., Sohlke J., and Rudel T. Shotgun proteome analysis of protein cleavage in apoptotic cells. Proteomics 5 (2005) 2123-2130
125. Liu M.C., Akle V., Zheng W., Dave J.R., Tortella F.C., Hayes R.L., et al. Comparing calpain- and caspase-3-mediated degradation patterns in traumatic brain injury by differential proteome analysis. Biochem J 394 (2006) 715-725
126. Mahrus S, Trinidad J, Burlingame A, Wells JA. Degradomics: the proteolysis of cell death. Molecular & Cellular Proteomics 2007; 6: 5.2.
127. Doucet A., Butler G.S., Rodriguez D., Prudova A., and Overall C.M. Metadegradomics toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome. Molecular & Cellular Proteomics 7 (2008) 1925-1951
128. Doucet A., and Overall C.M. Protease proteomics: revealing protease in vivo functions using systems biology approaches. Mol Aspects Med 29 (2008) 339-358
129. Lamkanfi M., Kanneganti T.D., Van Damme P., Vanden Berghe T., Vanoverberghe I., Vandekerckhove J., et al. Targeted peptidecentric proteomics reveals caspase-7 as a substrate of the caspase-1 inflammasomes. Molecular & Cellular Proteomics 7 (2008) 2350-2363
130. Schilling O., and Overall C.M. Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites. Nat Biotechnol 26 (2008) 685-694
131. Van Damme P., Vandelkerckhove J., and Gevaert K. Disentanglement of protease substrate repertoires. Biol Chem 389 (2008) 371-381
132. Van Damme P., Maurer-Stroh S., Plasman K., Van Durme J., Colaert N., Timmerman E., et al. Analysis of protein processing by N-terminal proteomics reveals novel species-specific substrate determinants of granzyme B orthologs. Molecular & Cellular Proteomics 8 (2009) 258-272
133. Vince J.W., and Reithmeier R.A.F. Identification of the carbonic anhydrase II binding site in the Cl-/HCO3-anion exchanger AE1. Biochemistry 39 (2000) 5527-5533
134. Chu H., Breite A., Ciraolo P., Franco R.S., and Low P.S. Characterization of the deoxyhemoglobin binding site on human erythrocyte band 3: implications for O-2 regulation of erythrocyte properties. Blood 111 (2008) 932-938
135. Campanella M.E., Chu H., and Low P.S. Assembly and regulation of a glycolytic enzyme complex on the human erythrocyte membrane. Proc Natl Acad Sci USA 102 (2005) 2402-2407
136. Campanella M.E., Chu H., Wandersee N.J., Peters L.L., Mohandas N., Gilligan D.M., et al. Characterization of glycolytic enzyme interactions with murine erythrocyte membranes in wild-type and membrane protein knockout mice. Blood 112 (2008) 3900-3906
137. Brunati A.M., Bordin L., Clari G., James P., Quadroni M., Baritono E., et al. Sequential phosphorylation of protein band 3 by Syk and Lyn tyrosine kinases in intact human erythrocytes: identification of primary and secondary phosphorylation sites. Blood 96 (2000) 1550-1557
138. Minetti G., Piccinini G., Balduini C., Seppi C., and Brovelli A. Tyrosine phosphorylation of band 3 protein in Ca2+/A23187-treated human erythrocytes. Biochem J 320 (1996) 445-450
139. Mallozzi C., Di Stasi A.M.M., and Minetti M. Peroxynitrite modulates tyrosine-dependent signal transduction pathway of human erythrocyte band 3. FASEB J 11 (1997) 1281-1290
140. Mallozzi C., Di Stasi A.M.M., and Minetti M. Activation of src tyrosine kinases by peroxynitrite. FEBS Lett 456 (1999) 201-206
141. Mallozzi C., Di Stasi M.A.M., and Minetti M. Peroxynitrite-dependent activation of src tyrosine kinases lyn and hck in erythrocytes is under mechanistically different pathways of redox control. Free Radic Biol Med 30 (2001) 1108-1117
142. Minetti M., Mallozzi C., and Di Stasi A.M.M. Peroxynitrite activates kinases of the src family and upregulates tyrosine phosphorylation signaling. Free Radic Biol Med 33 (2002) 744-754
143. Ciana A., Minetti G., and Balduini C. Phosphotyrosine phosphatases acting on band 3 in human erythrocytes of different age: PTP1B processing during cell ageing. Bioelectrochemistry 62 (2004) 169-173
144. Minetti G., Ciana A., and Balduini C. Differential sorting of tyrosine kinases and phosphotyrosine phosphatases acting on band 3 during vesiculation of human erythrocytes. Biochem J 377 (2004) 489-497
145. Matarrese P., Straface E., Pietraforte D., Gambardella L., Vona R., Maccaglia A., et al. Peroxynitrite induces senescence and apoptosis of red blood cells through the activation of aspartyl and cysteinyl proteases. FASEB J 19 (2005) 416-418
146. Serafini M., Mallozzi C., Di Stasi A.M.M., and Minetti M. Peroxynitrite-dependent upregulation of Src kinases in red blood cells: strategies to study the activation mechanisms. Methods Enzymol 396 (2005) 215-229
147. Pietraforte D., Matarrese P., Straface E., Gambardella L., Metere A., Scorza G., et al. Two different pathways are involved in peroxynitrite-induced senescence and apoptosis of human erythrocytes. Free Radic Biol Med 42 (2007) 202-214
148. Metere A, Iorio E, Pietraforte D, Podo F, Minetti M. Peroxynitrite signaling in human erythrocytes: Synergistic role of hemoglobin oxidation and band 3 tyrosine phosphorylation. Archives of Biochemistry and Biophysics 2008.
149. Daniels G. Functions of red cell surface proteins. Vox Sang 93 (2007) 331-340